Cutaneous Squamous-Cell Carcinoma after Treatment with Ruxolitinib or Belumosudil.

MLA

Lee, Gun Ho, et al. “Cutaneous Squamous-Cell Carcinoma after Treatment with Ruxolitinib or Belumosudil.” The New England Journal of Medicine, vol. 389, no. 2, July 2023, pp. 188–90. EBSCOhost, https://doi.org/10.1056/NEJMc2304157.

APA

Lee, G. H., Guzman, A. K., Divito, S. J., Soiffer, R. J., Silk, A. W., & Schmults, C. D. (2023). Cutaneous Squamous-Cell Carcinoma after Treatment with Ruxolitinib or Belumosudil. The New England Journal of Medicine, 389(2), 188–190. https://doi.org/10.1056/NEJMc2304157

Chicago

Lee, Gun Ho, Anthony K Guzman, Sherrie J Divito, Robert J Soiffer, Ann W Silk, and Chrysalyne D Schmults. 2023. “Cutaneous Squamous-Cell Carcinoma after Treatment with Ruxolitinib or Belumosudil.” The New England Journal of Medicine 389 (2): 188–90. doi:10.1056/NEJMc2304157.